Telix Pharmaceuticals Limited (ASX:TLX)
11.24
-0.09 (-0.79%)
At close: Jan 9, 2026
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 3.81 billion as of January 9, 2026. Its market cap has decreased by -54.41% in one year.
Market Cap
3.81B
Enterprise Value
4.13B
Revenue
1.01B
Ranking
n/a
PE Ratio
172.82
Stock Price
11.24
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 3.81B, an increase of 2,404.62%. That is a compound annual growth rate of 48.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 3.81B | 0.36% |
| Dec 31, 2025 | 3.79B | -53.94% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.03B |
| Pro Medicus | 21.96B |
| Cochlear | 17.22B |
| Sonic Healthcare | 11.07B |
| Ramsay Health Care | 8.13B |
| Ansell | 4.77B |
| Mesoblast | 3.94B |
| 4DMedical | 2.47B |